Search Results

Site Search

COVID-19 weekly news: April 4-10 2022 - Insights

Topic's Include: Testing wastewater for COVID-19: The clearest path to understanding community infection, and the latest advice about COVID-19 boosters.

Mayo Clinic Laboratory and pathology research roundup: April 4 - Insights

This Feature Includes: Utility of Follow-up COVID-19 Antigen Tests After Acute SARS-CoV-2 Infection Among Healthcare Personnel.

Clinical microbiology at Mayo Clinic: A look back and ahead - Insights

The field of clinical microbiology has a long and distinguished history at Mayo Clinic. Since the early 1900s, the clinical microbiology team has played important and leading roles in advancing testing and patient care.

Phlebotomy Modules: Module 3 | Insights

Skip to Content MayoACCESS MayoLINK...

Phlebotomy Modules: Module 1 | Insights

Skip to Content MayoACCESS MayoLINK...

Phlebotomy Modules: Module 3 | Insights

Skip to Content MayoACCESS MayoLINK...

Phlebotomy Modules: Module 2 | Insights

Skip to Content MayoACCESS MayoLINK...

Mayo Clinic Laboratory and pathology research roundup: October 4 - Insights

This week's research roundup features: Tumor microenvironment CD14+ cells correlate with poor overall survival in patients with early-stage lung adenocarcinoma

Phlebotomy Modules: Module 1 | Insights

Skip to Content MayoACCESS MayoLINK...

Mayo Clinic Laboratory and pathology research roundup: July 12 - Insights

This week's research roundup features: PFKFB3 works on the FAK-STAT3-SOX2 axis to regulate the stemness in MPM.

Pediatric - Insights

Clinic’s commitment to meeting the needs of every patient, from the smallest to the tallest, is central to our approach to pediatric gastroenterology testing. Developed in collaboration with Mayo Clinic’s top-ranked GI experts, our...

Acquired Neuropathy Diagnostic Algorithm

Acquired Neuropathy Diagnostic Algorithm

Week in Review: June 3 - Insights

Today's highlights include: Spread of monkeypox underscores need for physicians to be ready to understand, Pfizer completes application to FDA for vaccine for children under 5, and connect is key to supporting multiple sclerosis patients.

Mayo Clinic Laboratory and Pathology Research Roundup: January 23 - Insights

This week's research roundup feature: Measles virus (MV) vaccine strains have shown significant preclinical antitumor activity against glioblastoma (GBM), the most lethal glioma histology. In this first in human trial (NCT00390299), a...

New tests launched in April - Insights

In April 2022, Mayo Clinic Laboratories announced fourteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

Week in Review: May 27 - Insights

Today's highlights include: Long COVID affects more older adults, US has a new dominant COVID-19 strain, and Gianrico Farrugia explains how we can transform healthcare by moving from pipeline to platform.

Mayo Clinic Laboratory and pathology research roundup: July 18 - Insights

This week's research roundup feature: Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myeloma.

Pathways Case Studies: June 2022 - Insights

This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for June include the following sub-specialties: Dermatopathology, Gastroenterology...

March 2023 - Clinical Biochemistry - Insights

This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Clinical Biochemistry.

Research Archives - Page 7 of 33 - Insights

Skip to Content MayoACCESS MayoLINK...

Research Roundup Archives - Page 7 of 29 - Insights

Skip to Content MayoACCESS MayoLINK...

June 2022 - Dermatopathology - Insights

This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Dermatopathology.

Mayo Clinic Laboratory and pathology research roundup: August 2 - Insights

This week's research roundup features: Gastrointestinal stromal tumors mimicking gynecologic disease: clinicopathological analysis of 20 cases.

July 2022 - Laboratory Genetics and Genomics and Molecular Pathology - Insights

This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialties are Laboratory Genetics and Genomics and Molecular Pathology.

Whole exome sequencing for hereditary disorders - Insights

Cherisse Marcou, Ph.D., and Marissa Ellingson, M.S., CGC, discuss whole exome sequencing (WES) at Mayo Clinic Laboratories. The comprehensive evaluation uses next-generation sequencing to detect for single nucleotide variants, small...

Vector-borne diseases - Insights

Browse our full menu of individual tests and panels that aid in the diagnosis of vector-borne diseases.

Whole exome sequencing - Insights

Learn more about how whole exome sequencing at Mayo Clinic Laboratories can quickly end diagnostic testing odysseys for patients with suspected genetic disorders.

December 2022 - Pulmonary - Insights

This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Pulmonary Pathology.

MayoComplete - Insights

Learn about our menu of MayoComplete testing including a 515-gene panel and multiple disease-specific panels, which span the cancer spectrum.

Unveiling a novel hemoglobinopathy classification - Insights

In a recent discovery by Mayo Clinic Laboratories, a novel hemoglobinopathy category was identified and termed epsilon gamma thalassemia. The first instance of the disorder was found in 2017 when an obstetric patient underwent a routine...

Frequently asked questions - Insights

For patients at risk of plasma cell disorders, early identification is critical to ensure better outcomes. Mayo Clinic MASSFIX, our innovative approach uses matrix-assisted laser desorption/ionization time-of-flight mass spectrometry...

Frequently asked questions - Insights

For patients at risk of plasma cell disorders, early identification is critical to ensure better outcomes. Mayo Clinic MASSFIX, our innovative approach uses matrix-assisted laser desorption/ionization time-of-flight mass spectrometry...

Rapid hereditary breast cancer - Insights

Learn how our rapid breast cancer treatment panel delivers results in 10 to 14 days and detects 11 genes linked to lifetime breast cancer risk.

Mayo Clinic Laboratory and Pathology Research Roundup: February 27 - Insights

This week's research roundup feature: Both targeted therapies and immunotherapies provide benefit in resected Stage III melanoma. We hypothesized that the combination of targeted and immunotherapy given prior to therapeutic lymph node...

Week in Review: May 6 - Insights

Today's highlights include: Mental health needs rise as pandemic fluctuates, an algorithm that analyzes apple watch data shows early promise in detecting heart problems, and Minnesota physicians brace for Roe v. Wade decision

COVID-19 weekly news: March 7-11 2022 - Insights

Topic's Include: Losing sleep during the pandemic? It may be affecting your weight, heart, and overall health, and how to deal with anxiety, stress when the world feels overwhelming.

Week in Review: April 22 - Insights

Today's highlights include: Study mines cancer genetics to help with targeted treatment, Mayo Clinic to launch staffing tool app to find 'right nurse for the right role', and new blood biomarker may lead to early diagnosis of frontotemporal...

Industry Archives - Insights

Skip to Content MayoACCESS MayoLINK...

Week in Review Archives - Insights

Skip to Content MayoACCESS MayoLINK...

May 2023 - Renal Pathology - Insights

This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Renal Pathology.

March 2023 - Breast Pathology Case 1 - Insights

This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Breast Pathology.

Pediatrics - Insights

Mayo Clinic Laboratories’ commitment to pediatric care is supported by over 150 years of experience informing diagnoses and treatment plans.

Pathways Case Studies: July 2023 - Insights

This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for July include the following sub-specialties: Breast Pathology, Cytopathology &...

MayoComplete - Insights

Find out how our suite of MayoComplete next-generation sequencing panels puts patients on the right treatment path.

Thiopurine Management Testing for IBD - Mayo Clinic Laboratories

Thiopurine management is important because it can detect individuals with low thiopurinemethyltransferase (TPMT) activity who are at risk for excessive myelosuppression or severe hematopoietic toxicity when taking thiopurine drugs.

Stimulants - Insights

Learn more about how Mayo Clinic Laboratories’ targeted, high-resolution screening panel for stimulant use identifies and confirms the presence of 10 stimulants and phencyclidine (PCP) with a single test.

New tests launched in February - Insights

In February 2023, Mayo Clinic Laboratories announced fifteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

New tests launched in May - Insights

In May 2022, Mayo Clinic Laboratories announced multiple new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

Week in Review: March 25 - Insights

Today's Highlights Include: e-changing kidney swap, climate change is making allergy season even worse, and a Minnesota Milestone: A day without COVID-19 deaths.

Week in Review: March 18 - Insights

Today's Highlights Include: A new strategy for staying one step ahead of the virus, Pfizer CEO says another Covid booster will be needed, and Senate votes to make daylight saving time permanent.